Clinical Trials Browser

Completed × OTHER × IPI-926 × Clear all

NCT01383538 2017-08-08

FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma

Phase 1 Completed

Gastrointestinal

Adenocarcinoma, Neoplasms, Pancreatic Neoplasms

NCT01255800 2014-01-31

Pilot Study of Cetuximab and the Hedgehog Inhibitor IPI-926 in Recurrent Head and Neck Cancer

Phase 1 Completed

Head and Neck Neoplasms